Label: ACETAMINOPHEN tablet

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated November 18, 2024

If you are a consumer or patient please visit this version.

  • Active ingredient (in each caplet)

    Acetaminophen USP, 500 mg

  • Purpose

    Pain reliever/fever reducer

  • Uses

    ■ temporarily relieves minor aches and pains due to:


    ■ the common cold
    ■ headache
    ■ backache
    ■ minor pain of arthritis
    ■ toothache
    ■ muscular aches
    ■ premenstrual and menstrual cramps


    ■ temporarily reduces fever

  • Warnings


    Liver warning: This product contains acetaminophen. Severe liver damage may occur if you take
    ■ more than 4,000 mg of acetaminophen in 24 hours
    ■ with other drugs containing acetaminophen
    ■ 3 or more alcoholic drinks every day while using this product


    Allergy alert: acetaminophen may cause severe skin reactions. Symptoms may include:
    ■ skin reddening
    ■ blisters
    ■ rash
    If a skin reaction occurs, stop use and seek medical help right away

  • Ask a doctor before use if you have

    liver disease

  • Do not use

    ■ with any other drug containing acetaminophen (prescription or nonprescription). If you are not sure
    whether a drug contains acetaminophen, ask a doctor or pharmacist.
    ■ if you are allergic to acetaminophen or any of the inactive ingredients in this product

  • Ask a doctor or pharmacist before use if you are

    taking the blood thinning drug warfarin

  • Stop use and ask a doctor if

    ■ pain gets worse or lasts more than 10 days
    ■ fever gets worse or lasts more than 3 days
    ■ new symptoms occur
    ■ redness or swelling is present
    These could be signs of a serious condition

  • If pregnant or breast-feeding

    ask a health professional before use

  • Keep out of reach of children

    Keep out of reach of children

  • Overdose warning

    In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222) Quick medical attention is critical for adults as well as for children even if you do not notice any signs or symptoms.

  • Directions

    ■ do not take more than directed (see overdose warning)

    adults and children ■ take 2 caplets every 6 hours while symptoms last
    ■ do not take more than 6 caplets in 24 hours, unless directed by a doctor
    ■ do not use for more than 10 days unless directed by a doctor
    12 years and over

    children under 12 years ■ ask a doctor

  • Other information

    ■ store between 20-25°C (68-77°F). See USP Controlled Room Temperature.
    ■ see bottom of the label for lot number and expiration date

  • Inactive ingredients

    hydroxypropyl methyl cellulose, polyethylene glycol, povidone k-30, pregelatinized starch, sodium starch glycolate, stearic acid

  • Questions or comments?

    We would love to hear about your Member’s Mark experience! Call us toll-free at 1-877-770-3183 Mon-Fri 8:00 AM EST to 5:00 PM PST

  • PDP

    APAP 500mg

  • INGREDIENTS AND APPEARANCE
    ACETAMINOPHEN 
    acetaminophen tablet
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:68196-177
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    ACETAMINOPHEN (UNII: 362O9ITL9D) (ACETAMINOPHEN - UNII:362O9ITL9D) ACETAMINOPHEN500 mg
    Inactive Ingredients
    Ingredient NameStrength
    POVIDONE (UNII: FZ989GH94E)  
    STEARIC ACID (UNII: 4ELV7Z65AP)  
    POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  
    HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)  
    SODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2)  
    STARCH, CORN (UNII: O8232NY3SJ)  
    Product Characteristics
    ColorwhiteScoreno score
    ShapeOVALSize17mm
    FlavorImprint Code G;551
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:68196-177-61600 in 1 BOTTLE; Type 0: Not a Combination Product02/13/2024
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM01302/13/2024
    Labeler - SAM'S WEST INC (051957769)